Search

everythinglearnresearchcommunity

for

Search:↓

CCCA causes progressive hair loss in Black women, starting from a central scalp patch.

CCCA is a common, scarring hair loss in Black women that needs early detection.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Dupilumab may cause hair loss, so patients should be monitored.

Both treatments for alopecia areata showed similar modest effectiveness.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Scalp sarcoidosis can cause hair loss and needs accurate diagnosis and treatment with specific medications.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Tight hairstyles, especially on chemically treated hair, can cause reversible hair loss if caught early but may become permanent if not addressed.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

A boy's hair grew back after he stopped using orthodontic headgear that caused temporary hair loss.

Higher CRBP1 levels are linked to more severe alopecia areata.

Lichen planopilaris can unusually affect only the face, causing pigmentation and scarring.

Square-shaped hair loss can occur after treating a brain aneurysm due to localized radiation exposure.